1,5800 zł
0,00% 0,0000 zł
Milestone Medical Inc. (MMD)

Komunikaty spółki - MILESTONE

The change in the position of Chief Executive Officer
Consolidated quarterly report for second quarter 2017
Change in the shareholder structure of the Company
The change in the position of Chief Executive Officer
Receiving 510(k) FDA Clearance for CompuFlo® Epidural Instrument
List of Shareholders representing at least 5 % of the number of votes at the Annual General Meeting of the Shareholders on May 23, 2017
Appointment of Directors to the Board for new term of office
Appointment of an entity authorised to audit financial statements for the year 2017
Resolutions adopted by Annual General Meeting of Shareholders on May 23, 2017
Consolidated quarterly report for first quarter 2017
Regulatory Marketing Clearance to Sell Epidural and Intra-Articular Instruments and Disposables in Australia
Consolidated Annual Report for year ended December 31, 2016
Information on the date of the Annual Meeting of Shareholders
Information on the date of the Annual Meeting of Shareholders
Incidental violation of Section 16a of Best Practices of Companies Listed on NewConnect
Przejdź do strony za 5 Przejdź do strony »

Czy wiesz, że korzystasz z adblocka?
Reklamy nie są takie złe

To dzięki nim możemy udostępniać
Ci nasze treści.